Grant: Project Grant
McMaster University
$386,324.00
Pre-clinical evaluation of micro-tissue injection and self-assembly in vivo for cardiac repairs.
EF 2018-19
Résumé
The field of tissue engineering aims to create functional tissues from human cells and scaffolds that can replace damaged tissues in patients. However, to perform therapeutic repairs, lab-grown tissues often need to be delivered deep into the interior of a damaged organ in a patient while preserving a high-level of tissue structural organization, which makes the implantation surgery not only invasive but in many cases impossible to achieve. This project seeks to address the way we implement tissue engineered products by developing smart scaffolds and functional tissues that can be delivered minimally invasively and then self-assemble in the human body with external guidance. Specifically, we will develop a new therapeutic solution to deliver functional tissues for heart repairs in a minimally invasive manner.
Building on our prior success in cardiovascular tissue engineering, our lab is taking a leap forward to introduce a new strategy in tissue repairs with smart functional materials. We envision that incorporating magnetic particles inside a biodegradable scaffold will result in a biodegradable, magnetic-responsive scaffold-based carrier that can be used to support the culture of engineered heart muscles. Then a collection of these magnetic-scaffolds will serve as carriers to deliver and assemble the engineered heart tissues directly into the interior of the damaged heart muscle wall in a patient with minimally invasive injections. The magnetic-scaffolds will induce cellular alignment as well as tissue alignment with remotely controlled magnetic guidance. Finally, our scaffold materials will degrade as the heart heals. Collectively, these smart micro-scaffolds will guide tissue assembly in the body in a step-by-step fashion. This delivery method will allow us to reverse heart failure by delivering engineered heart tissues with a minimally invasive surgical procedure and by re-growing new muscles inside the heart.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
389359
Name
Zhang Boyang
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Biomedical Engineering
Projecttitle
Pre-clinical evaluation of micro-tissue injection and self-assembly in vivo for cardiac repairs.
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$386,324
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Cardiac Repair; Cardiomyocytes; Magnetic Materials; Scaffolds; Surgery; Tissue Engineering
Abstract
The field of tissue engineering aims to create functional tissues from human cells and scaffolds that can replace damaged tissues in patients. However, to perform therapeutic repairs, lab-grown tissues often need to be delivered deep into the interior of a damaged organ in a patient while preserving a high-level of tissue structural organization, which makes the implantation surgery not only invasive but in many cases impossible to achieve. This project seeks to address the way we implement tissue engineered products by developing smart scaffolds and functional tissues that can be delivered minimally invasively and then self-assemble in the human body with external guidance. Specifically, we will develop a new therapeutic solution to deliver functional tissues for heart repairs in a minimally invasive manner.
Building on our prior success in cardiovascular tissue engineering, our lab is taking a leap forward to introduce a new strategy in tissue repairs with smart functional materials. We envision that incorporating magnetic particles inside a biodegradable scaffold will result in a biodegradable, magnetic-responsive scaffold-based carrier that can be used to support the culture of engineered heart muscles. Then a collection of these magnetic-scaffolds will serve as carriers to deliver and assemble the engineered heart tissues directly into the interior of the damaged heart muscle wall in a patient with minimally invasive injections. The magnetic-scaffolds will induce cellular alignment as well as tissue alignment with remotely controlled magnetic guidance. Finally, our scaffold materials will degrade as the heart heals. Collectively, these smart micro-scaffolds will guide tissue assembly in the body in a step-by-step fashion. This delivery method will allow us to reverse heart failure by delivering engineered heart tissues with a minimally invasive surgical procedure and by re-growing new muscles inside the heart.
Competitiondate
201809
Approvedterm2
4 yrs 0 mth
Pinamesdelim
Zhang, Boyang
Approvedterm
4 ans 0 mois
Cihrcontribution2
~ $386,324~ $0~